BCCA Purchases RainDance Platform for Cancer Predisposition Gene Sequencing | GenomeWeb

The British Columbia Cancer Agency has purchased RainDance Technologies' ThunderStorm microdroplet PCR platform for use in its Clinical Diagnostic Genomics group, the company said this week.

According to RainDance, over the next two years, BCCA researchers plan to sequence cancer predisposition genes in more than 2,000 samples from patients with a hereditary predisposition to various types of cancer. The researchers want to use that data to guide clinical management.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.